beta 2-Microglobulin in clinical medicine

Area of Science:

• Biochemistry
• Nephrology
• Immunology

Background:

• Beta 2-microglobulin (B2M) is a protein produced at a constant rate in normal individuals.
• Its primary elimination route is via renal filtration and proximal tubular reabsorption/degradation.
• Dysfunction in proximal tubules increases urinary B2M concentration.

Purpose of the Study:

• To review the current understanding of beta 2-microglobulin metabolism and its clinical utility.
• To explore the factors influencing serum and urinary B2M levels.
• To highlight the diagnostic significance of B2M in various medical conditions.

Main Methods:

• Literature review of studies on beta 2-microglobulin production, catabolism, and clinical measurements.
• Analysis of renal handling of B2M, including glomerular filtration and tubular reabsorption.
• Correlation of B2M levels with glomerular filtration rate, synthesis rates, and disease states.

Main Results:

• Normal B2M production is constant, with over 99.9% of filtered B2M reabsorbed and degraded by proximal tubules.
• Serum B2M levels are influenced by glomerular filtration rate and synthesis rate.
• Elevated serum B2M is associated with advanced malignancy, lymphoid B-cell proliferation, and inflammatory disorders involving lymphopoiesis.

Conclusions:

• Beta 2-microglobulin levels in serum and urine provide valuable diagnostic information.
• Measurements are useful for assessing renal function and detecting conditions like malignancy and inflammatory diseases.
• Local B2M production can be inferred from its concentration in body fluids other than plasma and urine.